I am a Translational Biologist (PhD, PGCHE, FHEA) with over nine years of experience developing advanced human-relevant models for oncology research, precision medicine, and therapeutic discovery.
My expertise lies in designing and applying patient-derived organoid, ex vivo, and multicellular platforms that improve the prediction of therapeutic response and support decision-making across the drug development pipeline.
My work focuses on building scalable and biologically relevant systems that capture tumour heterogeneity, tumour microenvironment interactions, and patient-specific disease biology. I have extensive experience developing 3D organoid models, immune-oncology screening platforms, stromal-tumour co-cultures, precision-cut tissue platforms, and multi-omics workflows to support target validation, mechanism-of-action studies, biomarker discovery, and candidate prioritisation.
Throughout my career, I have led collaborative research programmes and strategic partnerships with leading biotechnology and pharmaceutical organisations. These collaborations have delivered next-generation preclinical models and screening approaches designed to improve translational predictability and accelerate the translation of scientific discoveries into patient benefit.
I have a strong track record in establishing large-scale patient-derived organoid biobanks, coordinating complex translational research programmes, and integrating clinical, experimental, and computational datasets to generate actionable biological insights. My research has been published in leading journals, including Nature, Nature Genetics, Cancer Research Communications, and Cell Reports Methods, and I was honoured to receive the 2024 Rising Star in Life Sciences Award.
My experience spans scientific leadership, project management, stakeholder engagement, and the development of high-performing multidisciplinary teams.
My goal is to advance predictive model systems and translational technologies that increase the success rate of oncology drug development and enable more personalised treatment strategies.
Expert in Synthecon 3D Cell Culture System RCCS : Microgravity - Rotating Wall Vessels - Organoids
PhD-level Tissue Engineer, science communicator, aspiring analyst developer. Experienced in pluripotent stem cells (iPSC), 2D/3D cell culture, organoids, in vitro cardiovascular biology and organ-on-a-chip applications. Passionate about alternatives to animal models following the 3R principle, and science communication to non-experts and general audience. Nowadays taking on new challenges as an analyst developer in the fintech industry, while keeping close ties with the scientific community and the exciting advancements in organoids and NAMs.
Scientist specialized in 3D biology with hands-on experience in high-throughput screening using physiologically relevant models. During my PhD, I focused on developing and optimizing 3D cell culture assays (such as spheroids, organoids, and 3D colony formation assays) for use in high-throughput settings, gaining strong expertise in assay design and imaging. In my industry role, I contributed to the automation of complex 3D biology workflows, supporting decision-making through advanced imaging and AI-based image analysis. I’ve worked extensively with iPSCs, adult stem cells, and various 3D assay formats, driving innovation at the interface of cell biology, automation, and data science.